卵巢癌患者血小板聚集率升高:不仅仅是血小板数增加
Zitha Redempta Isingizwe1, Brooke A Meelheim2, Doris Mangiaracina Benbrook1,2
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Cancers
|November 9, 2024
概括
卵巢癌患者由于血小板数量增加和血小板行为的改变而增加了血小板聚合,这表明抗血小板药物可以预防血栓形成.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 卵巢癌与血小板数量升高有关,这与疾病严重程度和血栓形成风险相关.
- 这项研究调查了卵巢癌中血小板聚合增加是否源于血小板数量或血小板功能的改变.
研究的目的:
- 确定卵巢癌患者血小板计数,血小板行为和聚合之间的关系.
- 探索抗血小板疗法在这种患者群体中预防血栓形成的潜力.
主要方法:
- 卵巢癌患者的血小板聚合与使用富血小板血 (PRP) 和标准化血小板计数的健康对照进行了比较.
- 评估了血小板激活标志物 (P-选择素,β-血球蛋白) 和全血计数 (血小板,白细胞).
- 使用了阿拉基酸,腺二酸和原作为血小板激动剂.
主要成果:
- 卵巢癌患者和对照患者的血小板聚合率和数量显著更高,不论方法 (PRP体积或血小板数量).
- 未经治疗的卵巢癌患者表现出血中血小板激活标志物P-选择素和β-血小板球蛋白水平升高.
- 化疗前,血小板和白细胞数量升高,化疗后下降.
结论:
- 卵巢癌中血小板聚合的增加是由血小板数量的增加和血小板行为的改变驱动的.
- 这些发现支持研究抗血小板药物,以减轻卵巢癌患者的血栓形成风险.
相关概念视频
Formation of the Platelet Plug
4.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
4.6K
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
471
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
471


